Voices
Rami Manochakian
Rami Manochakian/X

Rami Manochakian Shares MARIPOSA Study Results Presented at WCLC25

Rami Manochakian, Vice President of the North American Neuroendocrine Tumor Society, shared a post by James Chih-Hsin Yang et al. published in NEJM, on X, adding:

”Hot off the press.

Just published NEJM

Overall Survival Results of:

MARIPOSA Study of:

Amivantamab plus Lazertinib vs Osimertinib in 1st line Treatment of EGFR+ Advanced Non-Small Cell LungCancer.

Reminder that we have now two excellent (but different) combination regimens:

Amivantamab + Lazertinib (MARIPOSA)
Osimertinib + Chemotherapy (FLAURA2) with OS data just presented IASLC, WCLC25”

Title: Overall Survival with Amivantamab–Lazertinib in EGFR-Mutated Advanced NSCLC

Authors: James Chih-Hsin Yang, Shun Lu, Hidetoshi Hayashi, Enriqueta Felip, Alexander I. Spira, Nicolas Girard, Yu Jung Kim, Se-Hoon Lee, Yurii Ostapenko, Pongwut Danchaivijitr, Baogang Liu, Adlinda Alip, Ernesto Korbenfeld, Josiane Mourão Dias, Benjamin Besse, Antonio Passaro, Ki-Hyeong Lee, Hailin Xiong, Soon-Hin How, Ying Cheng, Gee-Chen Chang, Hiroshige Yoshioka, Michael Thomas, Danny Nguyen, Sai-Hong Ignatius Ou, Sanjay Mukhedkar, Kumar Prabhash, Manolo D’Arcangelo, Jorge Alatorre-Alexander, Juan Carlos Vázquez Limón, Sara Alves, Daniil Stroyakovskiy, Marina Peregudova, Mehmet Ali Nahit Şendur, Ozan Yazici, Raffaele Califano, Vanesa Gutiérrez Calderón, Filippo de Marinis, Sang-We Kim, Shirish M. Gadgeel, Scott Owen, John Xie, Tao Sun, Jaydeep Mehta, Raja Venkatasubramanian, Mariah Ennis, Elizabeth Fennema, Mahesh Daksh, Amy Roshak, Julie Man, Roland E. Knoblauch, Joshua M. Bauml, Mahadi Baig, Sujay Shah, Seema Sethi, Byoung Chul Cho

Read the Full Article.

MARIPOSA Study

More posts featuring Rami Manochakian on OncoDaily.

@OncoAlert Adlinda Alip Alexander I. Spira Amivantamab Amy Roshak Antonio Passaro Baogang Liu Benjamin Besse Byoung Chul Cho cancer Daniil Stroyakovskiy Danny Nguyen EGFR Elizabeth Fennema Enriqueta Felip Ernesto Korbenfeld Filippo de Marinis FLAURA2 Gee-Chen Chang Hailin Xiong Hidetoshi Hayashi Hiroshige Yoshioka James Chih-Hsin Yang Jaydeep Mehta John Xie Jorge Alatorre-Alexander Joshua M. Bauml Josiane Mourão Dias Juan Carlos Vázquez Limón Julie Man Ki Hyeong Lee Kumar Prabhash lazertinib lungcancer Mahadi Baig Mahesh Daksh Manolo D’Arcangelo Mariah Ennis Marina Peregudova MARIPOSA Mehmet Ali Nahit Şendur Michael Thomas NEJM Nicolas Girard OncoDaily Oncology OS osimertinib Ozan Yazici Pongwut Danchaivijitr Raffaele Califano Raja Venkatasubramanian Rami Manochakian Roland E. Knoblauch Sai-Hong Ignatius Ou Sang-We Kim Sanjay Mukhedkar Sara Alves Scott Owen Se-Hoon Lee Seema Sethi Shirish M. Gadgeel Shun Lu Soon-Hin How Sujay Shah Tao Sun The International Association for the Study of Lung Cancer (IASLC) Vanesa Gutiérrez Calderón WCLC25 Ying Cheng Yu Jung Kim Yurii Ostapenko